rood blauwe elepsis logo Belegger.nl

Guru Terug naar discussie overzicht

****MVIS 2007******

13.632 Posts
Pagina: «« 1 ... 556 557 558 559 560 ... 682 »» | Laatste | Omlaag ↓
  1. [verwijderd] 3 augustus 2007 17:04
    06:12 EDT Microvision-MVIS initiated with a Buy@MERI - Merriman sees long-term opportunities for the company to penetrate several large and expanding addressable markets, including handsets, and feels shares could trade in the $7-$10 range if it can stay on track with its milestones.

  2. blup1 3 augustus 2007 17:13
    en deze hadden we ook al

    Reuters upgrades MICROVISION, INC. from 3 to 1.
    05:00 a.m. 07/30/2007 Provided By Investars
    On July 30, 2007 Reuters upgraded MICROVISION, INC. from 3 to 1.

  3. [verwijderd] 6 augustus 2007 09:39
    Microvision to Present at the Canaccord Adams' 27th Global Growth Conference

    REDMOND, Wash.

    Microvision (NASDAQ:MVIS), the leader in light scanning technologies for display and imaging products, today announced that its CEO, Alexander Tokman, will speak at the Canaccord Adams' 27thGlobal Growth Conference on August 9, 2007, in Boston, Massachusetts.

    The Canaccord Adams Global Growth Conference is one of the oldest and largest programs showcasing both publicly traded and privately held growth companies. Mr. Tokman will make a short presentation during the general session and then a series of presentations at the breakout meetings at the InterContinental Boston Hotel from 9:30 a.m. to 5:00 p.m. ET on August 9th.

    Additional conference information can be found atwww.canaccordadams.com.

    About Microvision:www.microvision.com

    Microvision provides a display technology platform designed to enable next-generation display and imaging products for pico projectors, vehicles displays, and wearable displays that interface to mobile devices. The company also manufactures and sells its bar code scanner product line which features the company's proprietary MEMS technology.

    About Canaccord Adams:

    Canaccord Adams is a leading independent financial services firm committed to fostering the entrepreneurial economy by bringing corporate and institutional clients a unique perspective on global investment opportunities. With operations in research, sales and trading, and investment banking, our 225 professionals seek out emerging opportunities in our key sectors - Mining and Metals, Energy, Technology, Life Sciences, Real Estate, and Industrial Growth. Located in ten offices internationally, our experienced team generates focused, actionable ideas that identify opportunity and facilitate growth. Canaccord Adams, the international capital markets division of Canaccord Capital Inc., has operations in Toronto, London, Boston, Vancouver, New York, Calgary, Montreal, San Francisco, Houston and Chicago.

    Forward-Looking Statements Disclaimer

    Certain statements contained in this release, including those relating to commercialization and future products, future product form factor, product applications, as well as statements containing words like "could," "believe," and other similar expressions, are forward-looking statements that involve a number of risks and uncertainties. Factors that could cause actual results to differ materially from those projected in the Company's forward-looking statements include the following: our ability to raise additional capital when needed; our financial and technical resources relative to those of our competitors; our ability to keep up with rapid technological change; our dependence on the defense industry and a limited number of government development contracts; government regulation of our technologies; our ability to enforce our intellectual property rights and protect our proprietary technologies; the ability to obtain additional contract awards; the timing of commercial product launches and delays in product development; the ability to achieve key technical milestones in key products; dependence on third parties to develop, manufacture, sell and market our products; potential product liability claims and other risk factors identified from time to time in the Company's SEC reports, including the Company's Annual Report on Form 10-K filed with the SEC. Except as expressly required by the federal securities laws, we undertake no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events, changes in circumstances or any other reason.



    CONTACT: Microvision
    Matt Nichols, 425-882-6657 (media)
    or
    Hawk Associates
    Cale Smith/Julie Marshall, 305-451-1888 (investors)

    URL: www.businesswire.com



13.632 Posts
Pagina: «« 1 ... 556 557 558 559 560 ... 682 »» | Laatste |Omhoog ↑

Neem deel aan de discussie

Word nu gratis lid van Belegger.nl

Al abonnee? Log in

Direct naar Forum

Zoek alfabetisch op forum

  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
Forum # Topics # Posts
Aalberts 466 7.016
AB InBev 2 5.495
Abionyx Pharma 2 29
Ablynx 43 13.356
ABN AMRO 1.582 51.606
ABO-Group 1 22
Acacia Pharma 9 24.692
Accell Group 151 4.132
Accentis 2 264
Accsys Technologies 23 10.611
ACCSYS TECHNOLOGIES PLC 218 11.686
Ackermans & van Haaren 1 188
ADMA Biologics 1 34
Adomos 1 126
AdUX 2 457
Adyen 14 17.746
Aedifica 3 903
Aegon 3.258 322.696
AFC Ajax 538 7.088
Affimed NV 2 6.296
ageas 5.844 109.889
Agfa-Gevaert 14 2.049
Ahold 3.538 74.331
Air France - KLM 1.025 35.031
AIRBUS 1 11
Airspray 511 1.258
Akka Technologies 1 18
AkzoNobel 467 13.036
Alfen 16 24.766
Allfunds Group 4 1.470
Almunda Professionals (vh Novisource) 651 4.251
Alpha Pro Tech 1 17
Alphabet Inc. 1 406
Altice 106 51.198
Alumexx ((Voorheen Phelix (voorheen Inverko)) 8.486 114.822
AM 228 684
Amarin Corporation 1 133
Amerikaanse aandelen 3.836 242.995
AMG 971 133.248
AMS 3 73
Amsterdam Commodities 305 6.689
AMT Holding 199 7.047
Anavex Life Sciences Corp 2 491
Antonov 22.632 153.605
Aperam 92 14.992
Apollo Alternative Assets 1 17
Apple 5 381
Arcadis 252 8.772
Arcelor Mittal 2.033 320.682
Archos 1 1
Arcona Property Fund 1 286
arGEN-X 17 10.297
Aroundtown SA 1 219
Arrowhead Research 5 9.731
Ascencio 1 26
ASIT biotech 2 697
ASMI 4.108 39.093
ASML 1.766 106.749
ASR Nederland 21 4.458
ATAI Life Sciences 1 7
Atenor Group 1 485
Athlon Group 121 176
Atrium European Real Estate 2 199
Auplata 1 55
Avantium 32 13.661
Axsome Therapeutics 1 177
Azelis Group 1 64
Azerion 7 3.392